Index

• WellAir Brings Clean Air Technology to Brandywine Realty Trust Properties
• Xilio Therapeutics Appoints Stacey Davis as Chief Business Officer
• AppliedVR Partners with Kernel to Measure Brain Activity Changes Before, During, and After Virtual Reality (VR) Treatment of Chronic Pain
• Coherus BioSciences Appoints Dr. Jill O’Donnell-Tormey to its Board of Directors
• Sana Biotechnology Congratulates Senior Vice President and Head of T Cell Therapeutics, Terry Fry, M.D., on Additional Role at the University of Colorado’s Gates Institute
• NodThera Announces Clinical Progress for Lead NLRP3 Inflammasome Inhibitors and Candidate Selection of Novel Brain-Penetrant Compound
• Singular Genomics Announces Formation of Scientific Advisory Board
• Verve Therapeutics Announces Clearance of First VERVE-101 Clinical Trial Application and Outlines Global Clinical Development Strategy; Reports First Quarter 2022 Financial Results
• Rallybio wades into Sanofi storeroom for $3M rare disease deal
• Invetx raises $60.5 million to make long-lasting antibody therapies for cats and dogs
• Verve Therapeutics Reports Additional VERVE-101 and GalNAc-Lipid Nanoparticle Delivery Data in Non-Human Primates at TIDES USA 2022
• How cell & gene therapy startups can warm up to investors in this “biotech nuclear winter”
• Insilico Medicine expands synthetic lethality portfolio with nomination of a preclinical candidate targeting MAT2A for the treatment of MTAP-deleted cancers
• Denali Therapeutics Announces Achievement of RIPK1 Milestone for Phase 2 Clinical Trial Initiation in ALS by Sanofi
• AppliedVR taps Komodo Health to prove out its VR therapeutic for chronic pain
• WellAir Announces Kari Dixon as President and Chief Executive Officer
• Wellframe Addresses the Caregiver Crises Through an Expanded Program Aimed to Assist 250,000 Members by 2025
• Cytek Biosciences Appoints Todd Garland Chief Commercial Officer
• These fast, cheap tests could help us coexist with covid
• 1upHealth Announces SQL on FHIR® to Easily Ask Hard Questions of Healthcare FHIR® Data and Make Timely Real-World Decisions
• Zolgensma for dementia? AviadoBio gains orphan tag for one-dose gene therapy
• ABK Biomedical Announces First Patient Treated in First-in-Human Clinical Study with Eye90 microspheres™ for treatment of liver tumors
• MedCity Pivot Podcast: A conversation with Buoy Health’s chief medical officer
• Artemis Health Launches New Solution to Improve Evaluation and Optimization of Point Solutions
• Eleos Health and Zero Suicide Institute Join Forces to Incorporate Best Practices for Suicide Prevention Into Eleos’ Platform
• Turnstone Biologics Announces Executive Leadership Appointments
• Protenus Granted New Patent ‘Methods and Systems for Analyzing Accessing of Drug Dispensing Systems’
• Regeneron to Acquire Checkmate Pharmaceuticals and Its Investigational Immune Activator for Potential Use in Multiple Tumor Types
• Whatfix Acquires Leap.is to Expand Mobile Capabilities
• OTA Insight Acquires Kriya RevGEN, Adding Market-Leading Hotel Portfolio & Chain Revenue Intelligence Solution To Commercial Platform
• Innovent Receives NMPA Breakthrough Designation for IBI310, the Anti-CTLA-4 Monoclonal Antibody, Combined with Sintilimab in Advanced Cervical Cancer Treatment
• Insilico Medicine Announces Advancement of Its Preclinical Candidate for USP1 Synthetic Lethality Target to IND-enabling Studies for Various Oncological Disorders
• Orchard Therapeutics Announces Reimbursement Agreement Making Libmeldy Available for All Eligible MLD Patients in Italy
• PROOF DIAGNOSTICS SUBMITS REQUEST FOR EMERGENCY USE AUTHORIZATION SEEKING FIRST APPROVAL OF CRISPR-BASED MOLECULAR POINT-OF-CARE COVID-19 TEST
• Innovent Announces the Approval of Pemazyre® (pemigatinib) by the NMPA for the Treatment of Adults with Locally Advanced or Metastatic Cholangiocarcinoma with A FGFR2 Fusion or Rearrangement As Confirmed By A Validated Diagnostic Test That Have Progressed After at Least One Prior Line of Systemic Therapy
• Doceree Closes $11 Million Series A Funding Round Led by F-Prime Capital
• Eleos Health Raises $20M to Unlock In-Session Behavioral Health Voice Data
• Kyruus Welcomes Gail Airasian as General Manager of Emerging Markets as the Company Expands Its Platform to Serve the Broader Digital Health Market
• TraceLink Announces Product Availability Intelligence, Enabling Manufacturers to Predict Drug Shortages up to 90 Days in Advance with Greater Than 80% Accuracy
• HealthTap Joins Buoy Health’s Navigation Initiative to Match More People with the Right Health Care
• Rallybio Appoints Christine A. Nash and Hui Liu, Ph.D., to Its Board of Directors
• Ivenix to be Acquired by Fresenius Kabi
• Insilico Medicine Announces Strategic Collaboration with EQRx to Jointly Advance AI-driven Drug Discovery, Development and Commercialization for Multiple Targets
• AmplifyMD Raises $23 Million to Improve Patient Access to Specialty Care
• Innovent and Lilly Expand Strategic Partnership in Oncology
• WellAir Launches a New Advanced Air Cleaning Device in Europe with Independently Tested Industry Leading 99.9% Effectiveness Against Airborne Pathogens
• AppliedVR Renames Its FDA-approved Virtual Reality Therapeutic ‘RelieVRx’ and Announces Three-month Durability Study Results
• Aerium Therapeutics launches to develop novel therapeutics against COVID-19 and future pandemic threats
• Carrot Fertility rolls out age-inclusive benefits for menopause, low testosterone
• Notabene partners with global sanctions screening leader Refinitiv to deliver seamless counterparty sanction screening
• WellHive Announces Partnership with Kyruus to Integrate Systems and Optimize Care Navigation for Veterans
• Equip and Magellan Healthcare Collaborate to Offer Virtual Eating Disorder Treatment in California
• Atalanta Therapeutics Appoints Alfred Sandrock to Board of Directors
• UPMC and Kyruus Launch Strategic Partnership to Transform Digital Patient Access and Care Navigation
• Silq spins its technology into visibility for apparel manufacturing
• Flywire and Tribal Group Partner to Deliver Integrated Payments Solution for Education Market
• Proximie Selected As A Featured Innovator at LSI 2022 Medtech Investor Summit
• Owkin welcomes leading immuno-oncology professor as Chief Medical Officer and senior pharma exec as SVP Data Science
• Rialtic Completes Series A Extension Bringing Total Round to $45 Million
• Insilico Announces Successful Completion of Phase 0 Microdose Trial and Initiates Phase I Clinical Trial for its First AI-discovered Anti-fibrotic Product Candidate with Novel Target
• Benchling Expands Its Science Software Capabilities With Its First Acquisition
• Canary Technologies Raises $15 Million to Modernize the Hotel Tech Stack, Accelerate Growth & Global Market Penetration
• Avidity Biosciences Appoints Steve Hughes, M.D., as Chief Medical Officer
• Vendr acquires Blissfully, combining its SaaS buying services with management tools
• Independence Blue Cross and Patina announce agreement to offer Medicare Advantage members a new primary care experience
• Innovent Announces First Patient Dosing of Universal “Modular” CAR-T Cell product IBI345
• Whatfix Joins Guidewire PartnerConnect; New Marketplace App Provides Interactive, Real-Time User Guidance for Guidewire Technology
• OTA Insight continues its global expansion with new office in Brazil
• NOCD Selects Violet to Enhance Cultural and Identity Awareness Training to Therapists To Deliver More Personalized Care
• Equip Raises $58 Million Series B Funding Round to Revolutionize Eating Disorder Treatment
• Expressable grabs $15M to expand access to online speech therapy
• Centivo survey reveals devastating toll of the healthcare affordability crisis on US workers
• EmpiRx Health Reaffirms Commitment to Employees, Partners with Valor Performance to Strengthen Leadership & Employee Experience
• Kyruus Announces Record-Breaking Customer Growth in 2021, Welcoming HealthSparq and Connecting Millions of People with Care
• AGSAA, Biogen, LunaPBC, and Genetic Alliance Launch Community-Led Discovery Program for Aicardi-Goutières Syndrome
• Orchard Therapeutics Announces Historic Agreement Making Libmeldy Available by NHS England for MLD Patients
• F-Prime Capital Launches the F-Prime Fintech Index
• Simon Data Claims Top Leader Ranking from G2’s Grid for CDPs for Fourth Consecutive Quarter
• Four Seasons Astir Palace Hotel Partners with WellAir to Improve Indoor Air Quality
• Notabene Publishes The State of Crypto Travel Rule Compliance Report
• Snapsheet Announces 2021 Year in Review, Strongest 12 Months in Company History
• Logixboard Raises $32M Series B from Insight Partners to Continue Modernizing the $2T Freight Forwarding Industry
• Insilico Medicine Applauded by Frost & Sullivan for Enabling Rapid and Cost-Effective Drug Discovery and Development with Its Pharma.AI Platform
• Innovent Announces the Approval of Pemazyre® (pemigatinib) in Hong Kong Market for the Treatment of Adults With Locally Advanced Or Metastatic Cholangiocarcinoma With A FGFR2 Fusion Or Rearrangement That Have Progressed After At Least One Prior Line Of Systemic Therapy
• F-Prime backed startup nabs another $50M in bid to scale up AI R&D software
• Snapdocs First to Achieve MISMO Certification for eClosing System Providers
• Loans Canada and Even Financial Announce Strategic Partnership to Help Canadian Borrowers
• Xilio Therapeutics Announces Initiation of Patient Dosing in Phase 1/2 Clinical Trial of XTX202 for the Treatment of Patients with Solid Tumors
• CENTOGENE Joins Forces With Insilico Medicine for Niemann-Pick Disease Type C (NPC) Target Discovery, Applying Artificial Intelligence (AI) to Accelerate Orphan Drug Development
• WellAir Announces Strategic Partnership with the Association for Professionals in Infection Control and Epidemiology (APIC)